LSH

Lakeside Holding Limited Common Stock

0.9348 USD
-0.0079
0.84%
At close Jun 13, 4:00 PM EDT
After hours
0.9096
-0.0252
2.70%
1 day
-0.84%
5 days
-2.63%
1 month
2.49%
3 months
-12.64%
6 months
-62.46%
Year to date
-62.15%
1 year
-76.69%
5 years
-76.69%
10 years
-76.69%
 

About: Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services.

Employees: 50

0
Funds holding %
of 7,296 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

40% more funds holding

Funds holding: 5 [Q4 2024] → 7 (+2) [Q1 2025]

0.42% more ownership

Funds ownership: 0.39% [Q4 2024] → 0.81% (+0.42%) [Q1 2025]

11% less capital invested

Capital invested by funds: $73.7K [Q4 2024] → $65.5K (-$8.26K) [Q1 2025]

Research analyst outlook

We haven’t received any recent analyst ratings for LSH.

Financial journalist opinion

Neutral
GlobeNewsWire
1 month ago
Lakeside Announces Fiscal 2025 Third Quarter and Nine-Month Results
ITASCA, IL, May 15, 2025 (GLOBE NEWSWIRE) -- Lakeside Holding Limited (“Lakeside” or the “Company”) (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd., today announced financial results for its fiscal 2025 third quarter and nine months ended March 31, 2025.
Lakeside Announces Fiscal 2025 Third Quarter and Nine-Month Results
Neutral
PRNewsWire
3 months ago
LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION
ITASCA, Ill. , March 5, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd.
LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION
Neutral
PRNewsWire
3 months ago
Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results
ITASCA, Ill. , Feb. 14, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd.
Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results
Neutral
PRNewsWire
4 months ago
Lakeside Secures New Distribution Agreements with Kelun Pharmaceutical
Expanding Partnerships with Major Industry Players ITASCA, Ill. , Jan. 21, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market is pleased to announce that its wholly owned subsidiary, Hupan Pharmaceutical (Hubei) Co., Ltd.
Lakeside Secures New Distribution Agreements with Kelun Pharmaceutical
Neutral
PRNewsWire
5 months ago
Lakeside Partners with Huiyu Pharmaceutical to Revolutionize Oncology Drug Distribution
ITASCA, Ill. , Jan. 7, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market today announced that Hupan Pharmaceutical has entered into a strategic distribution agreement with Sichuan Huiyu Pharmaceutical Co., Ltd.
Lakeside Partners with Huiyu Pharmaceutical to Revolutionize Oncology Drug Distribution
Neutral
PRNewsWire
5 months ago
Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary
Agreement to Deliver Critical Medicines  ITASCA, Ill. , Dec. 17, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market is pleased to announce that Hupan Pharmaceutical has signed a Sales Agreement (the "Agreement") with Sinopharm Holding Hubei New Special Medicine Co., Ltd.
Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary
Neutral
PRNewsWire
6 months ago
Lakeside Holding to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
ITASCA, Ill , Dec. 3, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market operating under the brand American Bear Logistics ("ABL"), today announced it will be presenting at The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference to be held Wednesday, December 11th, 2024 at the New York Athletic Club in New York City. The conference offers emerging growth, and dynamic publicly traded companies access to institutional and individual investors in a unique one-on-one format during which Henry Liu, CEO of Lakeside will be participating in one-on-one meetings with investors and analysts throughout the day.
Lakeside Holding to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
Neutral
PRNewsWire
6 months ago
Lakeside Strengthens Market Position in China's Pharmaceutical Logistics with Key Sinopharm(Hubei) Contracts
ITASCA, Ill. , Nov. 25, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market operating under the brand American Bear Logistics ("ABL"), announces that Hupan Pharmaceutical (Hubei) Co., Ltd.
Lakeside Strengthens Market Position in China's Pharmaceutical Logistics with Key Sinopharm(Hubei) Contracts
Neutral
PRNewsWire
6 months ago
LAKESIDE HOLDING PROVIDES FIRST QUARTER OF FISCAL YEAR 2025 RESULTS
ITASCA, Ill. , Nov. 15, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market operating under the brand American Bear Logistics ("ABL"), today announced financial results for the first quarter of fiscal 2025, ended September 30, 2024.
LAKESIDE HOLDING PROVIDES FIRST QUARTER OF FISCAL YEAR 2025 RESULTS
Neutral
PRNewsWire
7 months ago
Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.
Acquisition Strengthens Lakeside's Pharmaceutical Logistics  Capabilities in China, Projected to Add US$7 Million in Annual Revenue ITASCA, Ill. , Nov. 11, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market operating under the brand American Bear Logistics (ABL), is pleased to announce that through its wholly-owned subsidiary Sichuan Hupan Jincheng Enterprise Management Co., Ltd.
Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.
Charts implemented using Lightweight Charts™